Influence of Age and Type 1 Diabetes Mellitus on Serological Test for Celiac Disease in Children |
Maheshwari, Anshu
(Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition/Alfred I. duPont Hospital for Children)
He, Zhaoping (Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition/Alfred I. duPont Hospital for Children) Weidner, Melissa Nicole (Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition/Alfred I. duPont Hospital for Children) Lin, Patrick (Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition/Alfred I. duPont Hospital for Children) Bober, Ryan (Department of Pediatrics, Sidney Kimmel College of Medicine) Del Rosario, Fernando J. (Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition/Alfred I. duPont Hospital for Children) |
1 | Lundin KE, Qiao SW, Snir O, Sollid LM. Coeliac disease - from genetic and immunological studies to clinical applications. Scand J Gastroenterol 2015;50:708-17. DOI |
2 | Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci 2012;19:88. DOI |
3 | Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, et al. Celiac disease: a comprehensive current review. BMC Med 2019;17:142. DOI |
4 | Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2018;16:823-36.e2. DOI |
5 | Akirov A, Pinhas-Hamiel O. Co-occurrence of type 1 diabetes mellitus and celiac disease. World J Diabetes 2015;6:707-14. DOI |
6 | Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012;107:1538-44; quiz 1537, 1545. DOI |
7 | Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol 2003;98:377-81. DOI |
8 | Castro-Antunes MM, Crovella S, Brandao LA, Guimaraes RL, Motta ME, Silva GA. Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil. Clinics (Sao Paulo) 2011;66:227-31. DOI |
9 | Not T, Tommasini A, Tonini G, Buratti E, Pocecco M, Tortul C, et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia 2001;44:151-5. DOI |
10 | Holmes GK. Screening for coeliac disease in type 1 diabetes. Arch Dis Child 2002;87:495-8. DOI |
11 | Holmes GK. Coeliac disease and Type 1 diabetes mellitus - the case for screening. Diabet Med 2001;18:169-77. DOI |
12 | Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol 2012;18:6036-59. DOI |
13 | Caja S, Maki M, Kaukinen K, Lindfors K. Antibodies in celiac disease: implications beyond diagnostics. Cell Mol Immunol 2011;8:103-9. DOI |
14 | Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128(4 Suppl 1):S38-46. DOI |
15 | Lagerqvist C, Dahlbom I, Hansson T, Jidell E, Juto P, Olcen P, et al. Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age. J Pediatr Gastroenterol Nutr 2008;47:428-35. DOI |
16 | Arigliani M, Rech Morassutti F, Fabris M, Melli P, Tonutti E, Cogo P. Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! Ital J Pediatr 2017;43:70. DOI |
17 | Lammi A, Arikoski P, Hakulinen A, Schwab U, Uusitupa M, Heinonen S, et al. Development of gliadinspecific immune responses in children with HLA-associated genetic risk for celiac disease. Scand J Gastroenterol 2016;51:168-77. DOI |
18 | Basso D, Guariso G, Bozzato D, Rossi E, Pescarin M, Fogar P, et al. New screening tests enrich antitransglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. Clin Chim Acta 2011;412:1662-7. DOI |
19 | Mozo L, Gomez J, Escanlar E, Bousono C, Gutierrez C. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients. J Pediatr Gastroenterol Nutr 2012;55:50-5. DOI |
20 | Sakly W, Mankai A, Ghdess A, Achour A, Thabet Y, Ghedira I. Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis. Clin Res Hepatol Gastroenterol 2012;36:598-603. DOI |
21 | Volta U, Granito A, Parisi C, Fabbri A, Fiorini E, Piscaglia M, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 2010;44:186-90. DOI |
22 | Chan AW, Butzner JD, McKenna R, Fritzler MJ. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Pediatrics 2001;107:E8. DOI |
23 | Ludvigsson JF, Brandt L, Montgomery SM. Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa. BMC Gastroenterol 2009;9:57. DOI |
24 | Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K, et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol 2011;45:673-8. DOI |
25 | Tsouka A, Mahmud FH, Marcon MA. Celiac disease alone and associated with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 2015;61:297-302. DOI |
26 | Pall H, Newhook LA, Aaron H, Curtis J, Randell E. Young age at diagnosis of type 1 diabetes is associated with the development of celiac disease-associated antibodies in children living in Newfoundland and Labrador, Canada. Children (Basel) 2015;2:403-11. DOI |
27 | Castellaneta S, Piccinno E, Oliva M, Cristofori F, Vendemiale M, Ortolani F, et al. High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study. Diabetes Care 2015;38:760-6. DOI |
28 | Matteucci E, Cinapri V, Quilici S, Lucchetti A, Mugnaini P, Giampietro O. Screening for coeliac disease in families of adults with Type 1 diabetes based on serological markers. Diabetes Nutr Metab 2001;14:37-42. |
29 | Waisbourd-Zinman O, Hojsak I, Rosenbach Y, Mozer-Glassberg Y, Shalitin S, Phillip M, et al. Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus. Dig Dis Sci 2012;57:1314-20. DOI |
30 | Rinawi F, Badarneh B, Tanous O, Bashir H, Tennenbaum-Rakover Y, Peleg S. Elevated anti-tissue transglutaminase antibodies in children newly diagnosed with type 1 diabetes do not always indicate coeliac disease. Acta Paediatr 2019;108:149-53. DOI |
31 | Liu E, Bao F, Barriga K, Miao D, Yu L, Erlich HA, et al. Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clin Gastroenterol Hepatol 2003;1:356-62. DOI |
32 | Boyd JC. Defining laboratory reference values and decision limits: populations, intervals, and interpretations. Asian J Androl 2010;12:83-90. DOI |
33 | Hagopian W, Lee HS, Liu E, Rewers M, She JX, Ziegler AG, et al.TEDDY Study Group. Co-occurrence of type 1 diabetes and celiac disease autoimmunity. Pediatrics 2017;140:e20171305. DOI |
34 | Maglio M, Florian F, Vecchiet M, Auricchio R, Paparo F, Spadaro R, et al. Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. Diabetes 2009;58:1578-84. DOI |
35 | Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52. DOI |
![]() |